Alumis

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$7.73
Previous Close
$7.84
Day Range
$7.65-$8.30
52W Range
$2.76-$10.49
Market Cap
$773.5M
Shares Short
3M

Financials

See more
Revenue (12 Mos)
$22.1M
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$22.1M
Diluted EPS
-$2.17

News

See more

Yahoo Finance • 21 days ago

Alumis Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Yahoo Finance • 3 months ago

Alumis to Participate in Upcoming September Investor Conferences

Yahoo Finance • 4 months ago

TYK2 Inhibitors Market to Drive Enormous Growth by 2034 Due to Strong Pipeline and Expanding Indications | DelveInsight

Yahoo Finance • 4 months ago

Alumis Completes Patient Enrollment in the Global LUMUS Phase 2b Trial of ESK-001, a Next-Generation Oral TYK2 Inhibitor for the Treatment of Systemic Lupus Erythematosus

About

CEO
Mr. Martin Babler Ph.D.
Address
280 East Grand Avenue, South San Francisco, CA, United States, 94080
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
221